Nesiritide following maze and mitral valve surgery

Journal of Cardiac Surgery

Volumn 23, Issue 5, 2008, Pages 431-436

  Beaver, Thomas M ^a   Winterstein, Almut ^b   Hess Jr , Phillip J ^a   Martin, Tomas D ^a   Arnaoutakis, George J ^a   Peng, Yong G ^a   Ejaz, A Ahsan ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CREATININE; DIURETIC AGENT; ENDOTHELIN 1; FUROSEMIDE; NESIRITIDE; PLACEBO;

ADULT; ARTICLE; CARDIOPULMONARY ARREST; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIURESIS; EXTUBATION; FEMALE; HEART LEFT ATRIUM; HUMAN; MALE; MITRAL VALVE; MITRAL VALVE REPAIR; MITRAL VALVE REPLACEMENT; OXYGENATION; RANDOMIZED CONTROLLED TRIAL; URINE VOLUME;

ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; CARDIAC SURGICAL PROCEDURES; DOUBLE-BLIND METHOD; EDEMA, CARDIAC; ENDOTHELIN-1; FEMALE; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE; NATRIURETIC AGENTS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 50049087189     PISSN: 08860440     EISSN: 15408191     Source Type: Journal    
DOI: 10.1111/j.1540-8191.2007.00552.x     Document Type: Article

References (32)

1. Rayburn BK, Bourge RC : Nesiritide: A unique therapeutic cardiac peptide. Rev Cardiovasc Med 2001 2 (Suppl 2 S25 31.
2. Hayashi Y, Ohtani M, Hiraishi T, et al : Postoperative synthetic human atrial natriuretic peptide infusion and oral spironolactone administration for a patient with giant atria and low plasma level of atrial natriuretic peptide. J Thorac Cardiovasc Surg 2002 124 : 206 209.
3. Kim KB, Lee CH, Kim CH, et al : Effect of the Cox maze procedure on the secretion of atrial natriuretic peptide. J Thorac Cardiovasc Surg 1998 115 : 139 146 discussion 146-147.
4. Suttner SW, Boldt J : Natriuretic peptide system: Physiology and clinical utility. Curr Opin Crit Care 2004 10 : 336 341.
5. Perera SA, Frame R, Brodman RF, et al : Atrial natriuretic peptide replacement therapy in rats subjected to biatrial appendectomy. J Thorac Cardiovasc Surg 1995 109 : 976 980.
6. Colucci WS, Elkayam U, Horton DP, et al : Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. N Engl J Med 2000 343 : 246 253.
7. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: A randomized controlled trial. JAMA 2002 287 : 1531 1540.
8. Abraham WT, Lowes BD, Ferguson DA, et al : Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure. J Card Fail 1998 4 : 37 44.
9. Remuzzi G, Perico N, Benigni A : New therapeutics that antagonize endothelin: Promises and frustrations. Nat Rev Drug Discov 2002 1 : 986 1001.
10. Noll G, Wenzel RR, Luscher TF : Endothelin and endothelin antagonists: Potential role in cardiovascular and renal disease. Mol Cell Biochem 1996 157 : 259 267.
11. Luscher TF, Barton M : Endothelins and endothelin receptor antagonists: Therapeutic considerations for a novel class of cardiovascular drugs. Circulation 2000 102 : 2434 2440.
12. Aronson D, Burger AJ : Intravenous nesiritide (human B-type natriuretic peptide) reduces plasma endothelin-1 levels in patients with decompensated congestive heart failure. Am J Cardiol 2002 90 : 435 438.
13. Dorman BH, Bond BR, Clair MJ, et al : Temporal synthesis and release of endothelin within the systemic and myocardial circulation during and after cardiopulmonary bypass: relation to postoperative recovery. J Cardiothorac Vasc Anesth 2000 14 : 540 545.
14. Entwistle JW 3rd., McLoughlin DE, Baghelai K : Postoperative nesiritide use following high-risk mitral valve replacement. Heart Surg Forum 2004 7 : E189 E190.
15. Moazami N, Damiano RJ, Bailey MS, et al : Nesiritide (BNP) in the management of postoperative cardiac patients. Ann Thorac Surg 2003 75 : 1974 1976.
16. Salzberg SP, Filsoufi F, Anyanwu A, et al : High-risk mitral valve surgery: Perioperative hemodynamic optimization with nesiritide (BNP). Ann Thorac Surg 2005 80 : 502 506.
17. Beaver TM, Winterstein A, Shuster JJ, et al : Effectiveness of nesiritide on dialysis or all cause mortality in patients undergoing cardiothoracic surgery. Clin Cardiol 2006 29 : 18 24.
18. Mentzer RM, Oz MC, Sladen RN, et al : Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery. J Am Coll Cardiol 2007 49 : 716 726.
19. Cox JL, Schuessler RB, Boineau JP : The development of the Maze procedure for the treatment of atrial fibrillation. Semin Thorac Cardiovasc Surg 2000 12 : 2 14.
20. Gaynor SL, Diodato MD, Prasad SM, et al : A prospective, single-center clinical trial of a modified Cox maze procedure with bipolar radiofrequency ablation. J Thorac Cardiovasc Surg 2004 128 : 535 542.
21. Ad N, Suyderhoud JP, Kim YD, et al : Benefits of prophylactic continuous infusion of furosemide after the maze procedure for atrial fibrillation. J Thorac Cardiovasc Surg 2002 123 : 232 236.
22. Yoshihara F, Nishikimi T, Sasako Y, et al : Preservation of the right atrial appendage improves reduced plasma atrial natriuretic peptide levels after the maze procedure. J Thorac Cardiovasc Surg 2000 119 : 790 794.
23. Albage A, van der Linden J, Bengtsson L, et al : Elevations in antidiuretic hormone and aldosterone as possible causes of fluid retention in the Maze procedure. Ann Thorac Surg 2001 72 : 58 64.
24. Sezai A, Shiono M, Orime Y, et al : Low-dose continuous infusion of human atrial natriuretic peptide during and after cardiac surgery. Ann Thorac Surg 2000 69 : 732 738.
25. Sward K, Valsson F, Odencrants P, et al : Recombinant human atrial natriuretic peptide in ischemic acute renal failure: A randomized placebo-controlled trial. Crit Care Med 2004 32 : 1310 1315.
26. Sinha AM, Breithardt OA, Schmid M, et al : Brain natriuretic peptide release in cardiac surgery patients. Thorac Cardiovasc Surg 2005 53 : 138 143.
27. Georges A, Forestier F, Valli N, et al : Changes in type B natriuretic peptide (BNP) concentrations during cardiac valve replacement. Eur J Cardiothorac Surg 2004 25 : 941 945.
28. de Denus S, Pharand C, Williamson DR : Brain natriuretic peptide in the management of heart failure: The versatile neurohormone. Chest 2004 125 : 652 668.
29. Huang H, Yao T, Wang W, et al : Continuous ultrafiltration attenuates the pulmonary injury that follows open heart surgery with cardiopulmonary bypass. Ann Thorac Surg 2003 76 : 136 140.
30. Hashimoto K, Miyamoto H, Suzuki K, et al : Evidence of organ damage after cardiopulmonary bypass. The role of elastase and vasoactive mediators. J Thorac Cardiovasc Surg 1992 104 : 666 673.
31. Burger AJ, Horton DP, LeJemtel T, et al : Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: The PRECEDENT study. Am Heart J 2002 144 : 1102 1108.
32. Colluci WS, Elkayam U, Horton D, et al : Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. NEJM 2000 343 : 246 253.